Osaka Organic Chemical Industry (4187) Q2 2025 earnings summary

Executive summary

• Net sales rose 13.4% year-over-year to ¥17.4 billion in 1H FY11/25, with all business segments contributing to growth.

• Operating profit surged 57.2% year-over-year to ¥2.92 billion, driven by higher sales and lower depreciation.

• Ordinary profit increased 52.9% year-over-year to ¥3.04 billion; profit attributable to owners of parent grew 5.6% to ¥2.13 billion.

• The company launched its new medium-term management plan, Progress & Development 2030, focusing on ESG and global market expansion, especially in specialty acrylic acid esters.

• Progress toward full-year forecast is strong, with 51.2% of net sales and 58.5% of operating profit achieved in the first half.

Financial highlights

• Net sales: ¥17.4 billion (+13.4% YoY); Operating profit: ¥2.92 billion (+57.2% YoY); Ordinary profit: ¥3.04 billion (+52.9% YoY); Profit attributable to owners: ¥2.13 billion (+5.6% YoY).

• Basic earnings per share for the period were ¥103.71, up from ¥95.44 a year earlier.

• Comprehensive income declined to ¥1,962 million from ¥2,198 million year-over-year.

• Total assets decreased to ¥58,637 million from ¥59,964 million at the previous fiscal year-end.

• Non-operating income rose due to insurance claim income; non-operating expenses increased from foreign exchange losses.

Outlook and guidance

• Full-year forecast: Net sales ¥34.0 billion (+4.0% YoY), operating profit ¥5.0 billion (+8.5% YoY), ordinary profit ¥5.2 billion (+9.4% YoY), profit attributable to owners ¥3.5 billion (-13.5% YoY).

• Annual dividend forecast revised upward to ¥69.00 per share.

• First-half results indicate favorable progress toward annual targets.